A comprehensive view of new dosage / format. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

ViiV Healthcare, Janssen Pharmaceutical receive FDA approval for label update for Cabenuva cabotegravir, non-nucleoside reverse transcriptase inhibitor rilpivirine injectable to treat HIV-1; approved dose is once-monthly or once every two months

CanSinoBIO's Convidecia approved in Malaysia as a heterologous booster for individuals aged 18 and older who have received two doses of inactivated COVID-19 vaccine

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count